Research ArticleExperimental Studies

Atorvastatin Exerts More Selective Inhibitory Effects on hMCT2 than on hMCT1 and hMCT4

ATSUSHI YAMAGUCHI, YUTO MUKAI, TOMOYA SAKUMA, AYAKO FURUGEN, KATSUYA NARUMI and MASAKI KOBAYASHI
Anticancer Research July 2023, 43 (7) 3015-3022; DOI: https://doi.org/10.21873/anticanres.16472

Article Information

vol. 43 no. 7 3015-3022
DOI 
https://doi.org/10.21873/anticanres.16472
PubMed 
37351987
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received April 10, 2023
  • Revision received April 29, 2023
  • Accepted May 2, 2023
  • Published online June 23, 2023.
Copyright & Usage 
Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. ATSUSHI YAMAGUCHI1,2,
  2. YUTO MUKAI2,
  3. TOMOYA SAKUMA2,
  4. AYAKO FURUGEN2,
  5. KATSUYA NARUMI2 and
  6. MASAKI KOBAYASHI2⇑
  1. 1Department of Pharmacy, Hokkaido University Hospital, Sapporo, Japan;
  2. 2Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan
  1. Correspondence to: Masaki Kobayashi, Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060-0812, Japan. Tel/Fax: +81 117063770, e-mail: masaki{at}pharm.hokudai.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Atorvastatin Exerts More Selective Inhibitory Effects on hMCT2 than on hMCT1 and hMCT4
ATSUSHI YAMAGUCHI, YUTO MUKAI, TOMOYA SAKUMA, AYAKO FURUGEN, KATSUYA NARUMI, MASAKI KOBAYASHI
Anticancer Research Jul 2023, 43 (7) 3015-3022; DOI: 10.21873/anticanres.16472
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords